BROWSE ALL ARTICLES BY TOPIC
Articles by Topic - Regulatory
Listing articles 11 to 20 of 138
Food industry employers may need to take a hard look at their processes for handling employee complaints about perceived food safety issues, given the provisions of a new interim final rule about how whistleblower complaints will be handled in the future.
The increased production of genetically modified crops around the globe has led to a higher number of incidents of low levels of GMOs being detected in traded food and feed, according to a FAO survey. As a result, there have been trade disruptions between countries with shipments being blocked by importing countries and destroyed (burned) or returned to the country of origin.
FDA recently entered into a consent decree with the Center for Food Safety that sets firm deadlines for the agency’s submission of final rules implementing the FSMA to the Federal Register for publication.
Last month, the FDA published an interim final rule to further safeguard infant formula in the U.S. The rule, which sets standards for manufacturers to produce safe infant formula that supports healthy growth, is accompanied by two draft guidance documents for industry.
Identifying how ‘data quality challenges,’ high-risk facilities, and budgets factor into the future of FDA’s inspection capability
Facilities are hoping for extra compliance time as they navigate through preventative controls, cGMPs, exemptions, and Qualified Individual requirements associated with the animal feed rule
"This proposed rule will help reduce the likelihood of conditions during transportation that can lead to human or animal illness or injury," said Michael R. Taylor, the FDA's deputy commissioner for foods and veterinary medicine. "We are now one step closer to fully implementing the comprehensive regulatory framework for prevention that will strengthen the FDA's inspection and compliance tools, modernize oversight of the nation's food safety system, and prevent foodborne illnesses before...
A guidance document issued by the FDA in December aims to phase out the use of medically important antimicrobial drugs for food production purposes. The document asks companies that make animal pharmaceuticals to voluntarily revise the labels of these products to remove production uses—such as enhancing animal growth or improving feed efficiency—and restrict these antimicrobials to therapeutic uses under veterinary oversight.
The FDA’s release in December of a proposed rule that would require the nation’s largest food businesses to take steps to prevent intentional food adulteration met with little surprise, though some in the food industry feel the guideline is both too specific and too broad.
If a foreign country is able to achieve a ‘comparable’ food safety system, it can cut through the regulatory red tape and make it easier for its food producers to export to the U.S.